Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-487-3 | CAS number: 13400-13-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.46 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 37.5
- Dose descriptor starting point:
- LOAEL
- Value:
- 13.9
- Modified dose descriptor starting point:
- LOAEC
- Value:
- 17.2 mg/m³
- Explanation for the modification of the dose descriptor starting point:
There are no relevant experimental data on the repeated exposure by inhalation. A conservative approach is used assuming a 50 % absorption rate via the oral route (end route) as compared to the inhalation route (starting route).
- AF for dose response relationship:
- 3
- Justification:
- The assessment factor was used for extrapolation from LOAEC to NOAEC.
- AF for differences in duration of exposure:
- 1
- Justification:
- No time extrapolation factor is needed since a chronic toxicity study is available.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Respiratory interspecies differences are fully covered by the factors used for route to route extrapolation.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default factor according to ECHA guidance document.
- AF for intraspecies differences:
- 5
- Justification:
- Default factor according to ECHA guidance document.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5.2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 37.5
- Dose descriptor starting point:
- LOAEL
- Value:
- 13.9 mg/kg bw/day
- Modified dose descriptor starting point:
- LOAEL
- Value:
- 139 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The physicochemical properties of the parent substance and its respective ions, being charged, do not favour dermal absorption. The ionic nature of the inorganic salt will hinder dermal uptake. Pendic and Milivojevic (1966) conducted a dermal absorption study on the structural analogous substance cesium chloride (CsCl) in rats. In this study it was determined that only a minor fraction (approximately 3 %) of radiolabeled CsCl applied to a skin surface of several cm² was absorbed within 6 hours and became systemically available. It is therefore assumed that the test items absorption corresponds to 10 % of the oral uptake.
- AF for dose response relationship:
- 3
- Justification:
- The assessment factor was used for extrapolation from LOAEL to NOAEL.
- AF for differences in duration of exposure:
- 1
- Justification:
- No time extrapolation factor is needed since a chronic toxicity study is available.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Metabolism of cesium fluoride as an inorganic salt can be excluded. There are no reasons to assume that this behaviour which is based on the physico-chemical properties of the substance will be different between rats and humans. Therefore, it is considered to be justified to apply substance-specific assessment factors accounting for a correction for differences in metabolic rate of 1 instead of using the respective default factor of 4.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default factor according to ECHA guidance document.
- AF for intraspecies differences:
- 5
- Justification:
- Default factor according to ECHA guidance document.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further aassessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
General
No respective experimental systemic data for cesium fluoride are available. Consequently, read-across was applied using study results from cesium hydroxide monohydrate, cesium chloride and sodium fluoride to cover both ions of the target substance. Please refer to IUCLID section 13 for read-across justification. The DNEL derivation is based on the LOAEL for sodium fluoride as worst case.
DNEL derivation is performed under consideration of the recommendations of ECHA REACH Guidance (2010).
Long term exposure- systemic effect
Inhalation exposure
A subchronic repeated dose toxicity test with cesium fluoride is not available. Consequently, read-across was applied using study results from sodium fluoride (1990).
In order to derive the worker DNEL (long-term inhalation exposure), the LOAEL assessed in the chronic repeated dose oral toxicity study with the structural analogue sodium fluoride was used (NOAEL 3.75 mg/kg bw/day). The DNEL derivation is based on the calculated LOAEL for cesium fluoride of 13.9 mg/kg bw/day.
Correction of the dose descriptor
Oral NOAEL: 13.9 mg/kg bw/day
sRV(rat): 0.38 m³/kg bw (8 hours) [standard respiratory volume of the rat]
ABS oral (rat) / ABS inhalation (human): 0.5 [ratio of oral absorption in the rat to inhalative absorption in the human]
sRV (human) / wRV (human): 6.7 m³/10 m³ = 0.67 m³ [ratio of human standard respiratory volume to worker respiratory volume]
Differences experimental/human exposure conditions: 1.4 [ratio of 7 d exposure of the rat to 5 d exposure of the human]
The inhalatory NOAEC = 13.9 mg/kg bw/d x 1/0.38 m³ x 0.5 x 0.67 m³ x 1.4 = 17.2 mg/m³.
Calculation of the worker DNEL
Corrected inhalatory NOAEC for worker: 17.2 mg/m³
Assessment factor for exposure duration (chronic): 1
Assessment factor for intraspecies differences (worker): 5
Assessment factor for other interspecies differences: 2.5
Assessment factor for dose-response relationship: 3
Worker DNEL (inhalation exposure) = 17.2 mg/m³ / (1 x 5 x 2.5 x 3) = 17.2 / 37.5 = 0.46 mg/m³
Dermal exposure
In order to derive the worker DNEL (long-term dermal exposure), the LOAEL assessed in the chronic repeated dose oral toxicity study was used. The LOAEL of the test item sodium fluoride was 3.75 mg/kg bw/day. The DNEL derivation is based on the calculated LOAEL for cesium fluoride of 13.9 mg/kg bw/ day. Considering the appropriate assessment factors, the worker DNEL (long-term dermal exposure) is calculated as follows:
Correction of the dose descriptor
Dose descriptor of relevant study: 139 mg/kg bw/d (NOAEL x 10; assuming 10 % dermal absorption)
Differences experimental/human exposure conditions: 1.4 [ratio of 7 d exposure of the rat to 5 d exposure of the human]
The dermal NOAEL = 139 mg/kg bw/d x 1.4 = 195 mg/kg bw/d
Calculation of worker DNEL
Corrected dermal NOAEL for worker: 195 mg/kg bw/d
Assessment factor for exposure duration (chronic): 1
Allometric scaling factor (rat to human): 1
Assessment factor for intraspecies differences (worker): 5
Assessment factor for other interspecies differences: 2.5
Assessment factor for dose-response relationship: 3
Taking the above mentioned assessment factors into account, the following worker DNEL is:
Worker DNEL (dermal exposure) = 195 mg/kg bw/day / (1 x 1 x 2.5 x 5 x 3) = 195 / 37.5 = 5.2 mg/kg bw/d
Acute/ short term exposure- systemic effect
Inhalation: There is no indication for acute systemic toxicity of cesium fluoride. The substance is not classified for inhalation toxicity. Also no peak exposure is expected and inhalation exposure is expected to be negligible. Therefore no DNEL is required.
Dermal: No acute dermal study was available with cesium fluoride. An LD50 value of > 2000 mg/kg bw was obtained in an animal study (EU method B.2, OECD 402) with cesium nitrate. The results were adapted by a read-across approach to cesium fluoride which was therefore not classified for acute systemic toxicity after dermal application. Therefore no DNEL was derived.
Acute and long term exposure- local effect
Respiratory irritation: The test item is classified for eye damage according Regulation (EC) No 1272/2008 (CLP). This implies that a potential damage to mucosal tissue may occur by inhalative exposure. Therefore, low hazard was applied for precautionary reasons. No threshold data could be derived from the respective studies/data. Thus, qualitative approach was applied to hazard and risk assessment with relevant RMM (ECHA CSA R.8, 2012).
Skin: The in vitro skin irritation study according to OECD 439 concluded not irritant for cesium fluoride. However it was classified as skin irritating based on an in vivo skin corrosion study with the source substance sodium fluoride for precautionary reasons. Thus, qualitative approach was applied to hazard and risk assessment with relevant RMM (ECHA CSA R.8, 2012).
Eye irritation: Based on in vivo eye irritation studies with aqueous sodium fluoride solution, cesium fluoride is classified for serious eye damage according to Regulation (EC) No 1272/2008 (CLP/GHS). The mechanism of effect is direct pH reactivity because sodium fluoride exhibits an alkaline pH of around 10. Although cesium fluoride shows a neutral pH in aqueous solution a qualitative approach (medium hazard) was applied to exposure and risk assessment with relevant RMM (ECHA CSR R.8, 2010).
References
- ECHA (2010). Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health. Version 2. ECHA-2010 -G-19–N.
- ECETOC (2010). Technical Report 110.Guidance on assessment factors to derive a DNEL.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.